Opal Biosciences buys drug development business, eyes manufacture

Infections diseases therapy company Opal Biosciences has bought a specialist pharmaceutical formulation business, boosting its capabilities in developing new drugs for clinical trials and manufacture. The Melbourne company bought Formulytica Pty Ltd which has in-house laboratories for developing formulations for topical and injectable drugs. The company provides a fee-for-service business for local and international clients…

Quasar launches phased array satellite ground station

Space industry startup Quasar Satellite Technologies has raised $12 million to commercialise a breakthrough technology that allows ground stations to communicate with hundreds of satellites at once. With ground stations typically talking to a single satellite, Quasar’s technology based on CSIRO’s phased array research will communicate with the thousands of nanosatellites now entering low earth…

Sparc Technologies shines in PFAS remediation

Graphene technology company Sparc Technologies has repeated tests that show a new use for its graphene enhanced products – adsorption of dangerous PFAS chemicals, aiding environmental remediation. In a quarterly activities report the Adelaide company said its PArGO product out-performed traditional activated carbon water treatment in relation to Per- and polyfluoroalkyl substances (PFAS). PArGO is…

Atomo Diagnostics HIV test to be more widely available

Rapid HIV test manufacturer Atomo Diagnostics will have its handheld test device more widely available in low and middle-income countries (LMICs) through an agreement with healthcare company Viatris Inc. Sydney’s Atomo has agreed to a multi-year expoansion of HIV tself-testing using its kits through global health agency Unitad and Viatris’subsidiary Mylan. The Mylan HIV Self-Test…